![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » DOV PHARMACEUTICAL GETS NASDAQ LETTER
DOV PHARMACEUTICAL GETS NASDAQ LETTER
Shares of DOV Pharmaceutical Inc. slipped to a fresh 52-week low after the biopharmaceutical company said it received a letter from the Nasdaq that it failed to comply with several listing requirements. The company's market value fell below $50 million
for 10 straight business days, and total assets and total revenue also fell
below $50 million.
Business
Week
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct